Provided by Tiger Trade Technology Pte. Ltd.

Immix Biopharma, Inc.

8.52
-0.2800-3.18%
Post-market: 8.520.00000.00%19:34 EDT
Volume:2.32M
Turnover:20.14M
Market Cap:606.54M
PE:-9.59
High:8.99
Open:8.88
Low:8.48
Close:8.80
52wk High:12.14
52wk Low:1.94
Shares:71.19M
Float Shares:56.78M
Volume Ratio:1.13
T/O Rate:4.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8883
EPS(LYR):-0.8930
ROE:-74.47%
ROA:-38.97%
PB:7.19
PE(LYR):-9.54

Loading ...

Jul 20, 2026

Major Issues Report

Form 8-K - Current report
Jun 05, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 29, 2026

Major Issues Report

Form 8-K - Current report
May 21, 2026

Major Issues Report

Form 8-K - Current report
May 21, 2026

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 21, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mar 30, 2026

Major Issues Report

Form 8-K - Current report
Mar 27, 2026

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 25, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 25, 2026

Major Issues Report

Form 8-K - Current report
Mar 25, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 17, 2026

Correspondence

Form CORRESP - Correspondence
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Nov 27, 2025

Correspondence

Form CORRESP - Correspondence
Nov 26, 2025

Major Issues Report

Form 8-K - Current report